dihexa peptide cream Dihexa | | 1401708-83-5 |

COA available upon request

01 Premium Peptides High-purity peptide sequences manufactured to exacting quality standards

Microvascular decompression may cause hearing loss, facial numbness or weakness, double vision, balance problems, cerebellar or brainstem injury, cerebrospinal fluid leakage, meningitis, wound infection, bleeding, stroke, seizures, anesthesia-related complications, persistence of pain, or recurrence after an initially successful result

BPC 157, of which the LD1 has not been achieved, has been implemented as an anti-ulcer peptide in inflammatory bowel disease trials and recently in a multiple sclerosis trial